Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics

Published:2016-01-07 Issue:10 Volume:18 Page:981-987
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Moreno L.,Linossi C.,Esteban I.,Gadea N.,Carrasco E.,Bonache S.,Gutiérrez-Enríquez S.,Cruz C.,Díez O.,Balmaña J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-015-1470-0.pdf

Reference30 articles.

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.

2. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996;12(3):333–7. doi: 10.1038/ng0396-333 .

3. Ford D, Easton FD, Stratton M, Narod SA, Goldgar DE, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA genes in breast cancer families. Am J Hum Genet. 1998;62:14.

4. Eccles DM, Evans DG, Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet. 2000;37:7.

5. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397–406. doi: 10.1200/JCO.2003.03.189 .

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner;Seminars in Oncology Nursing;2024-06

2. Risk-Reducing Surgery for Breast Cancer;Screening and Risk Reduction Strategies for Breast Cancer;2023

3. Quantification of Discordant Variant Interpretations in a Large Family-Based Study of Li-Fraumeni Syndrome;JCO Precision Oncology;2021-11

4. Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency;Croatian Medical Journal;2021-04

5. University students’ knowledge and readiness to practice genomic nursing in Nigeria;International Journal of Africa Nursing Sciences;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3